APOA2 and COVID-19: For example, the concentration of Apolipoprotein A-II (represented by peptide SPELQAEAK) is significantly increased during COVID-19 progression, as observed on the ZT Scan DIA platform, and this trend is similarly confirmed in the composite dataset (Fig. 6a, Supplementary Data 7—Statistics_composite dataset).